Hayley Virgil | Authors


PORT Not Recommended as Standard of Care for Completely Resected Stage IIIAN2 NSCLC

September 26, 2020

Post-operative radiotherapy was associated with a nonstatistically significant increase in disease-free survival in patients with completely resected stage IIIAN2 non-small cell lung cancer and therefore cannot be recommended as a standard of care.

Adding Nivolumab to Chemo Improves PFS, Elicits Higher ORR in Gastric/GEJ Cancers

September 24, 2020

The addition of nivolumab (Opdivo) to chemotherapy resulted in a statistically significant improvement in PFS and evoked higher ORRs in patients with previously untreated advanced or recurrent gastric and gastroesophageal junction cancer.